Cordero AM, Crider KS, Rogers LM, Cannon MJ, Berry RJ Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines. MMWR Morb Mortal Wkly Rep. 2015 Apr 24;64(15):421-3.
Czeizel AE, Dudas I Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992 Dec 24;327(26):1832-5. doi: 10.1056/NEJM199212243272602.
Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM Folate levels and neural tube defects. Implications for prevention. JAMA. 1995 Dec 6;274(21):1698-702. doi: 10.1001/jama.1995.03530210052030.
Lao TT Obstetric care for women with thalassemia. Best Pract Res Clin Obstet Gynaecol. 2017 Feb;39:89-100. doi: 10.1016/j.bpobgyn.2016.09.002. Epub 2016 Sep 23.
Leung CF, Lao TT, Chang AM Effect of folate supplement on pregnant women with beta-thalassaemia minor. Eur J Obstet Gynecol Reprod Biol. 1989 Dec;33(3):209-13. doi: 10.1016/0028-2243(89)90131-7.
Tripathi G, Kalra M, Mahajan A Folate supplementation in transfusion-dependent thalassemia: Do we really need such high doses? Indian J Med Paediatr Oncol. 2016 Oct-Dec;37(4):305. doi: 10.4103/0971-5851.195746. No abstract available.
Tso SC, Wong RL Folate status in pregnant Chinese women in Hong Kong. Int J Gynaecol Obstet. 1980;18(4):290-4. doi: 10.1002/j.1879-3479.1980.tb00498.x.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
